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Muscle wasting is common in mammals during extended periods of immobility. However, many small hibernating mammals manage to
avoid muscle atrophy despite remaining stationary for long periods during hibernation. Recent research has highlighted roles for short
non-coding microRNAs (miRNAs) in the regulation of stress tolerance. We proposed that they could also play an important role in
muscle maintenance during hibernation. To explore this possibility, a group of 10 miRNAs known to be normally expressed in skeletal
muscle of non-hibernating mammals were analyzed by RT-PCR in hibernating little brown bats,Myotis lucifugus. We then compared the
expression of these miRNAs in euthermic control bats and bats in torpor. Our results showed that compared to euthermic controls, sig-
niﬁcant, albeit modest (1.2–1.6 fold), increases in transcript expression were observed for eight mature miRNAs, including miR-1a-1,
miR-29b, miR-181b, miR-15a, miR-20a, miR-206 and miR-128-1, in the pectoral muscle of torpid bats. Conversely, expression of
miR-21 decreased by 80% during torpor, while expression of miR-107 remained unaﬀected. Interestingly, these miRNAs have been either
validated or predicted to aﬀect multiple muscle-speciﬁc factors, including myostatin, FoxO3a, HDAC4 and SMAD7, and are likely
involved in the preservation of pectoral muscle mass and functionality during bat hibernation.
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Skeletal muscle tissue diﬀerentiates early in vertebrate
embryogenesis and requires the combinatorial actions of
multiple signaling pathways. The mechanisms of maintain-
ing and remodeling skeletal muscle are of particular inter-
est, since skeletal muscle tissue is capable of adapting to the
changing physiological and environmental conditions [1].
For example, hypertrophy of skeletal muscle is induced
through increased muscle use and results in an enlarged
size, augmented ability to produce force, increased resis-
tance to fatigue and enhanced oxidative metabolism [1,2].
However, prolonged disuse or immobility of skeletal mus-1672-0229/$ - see front matter  2012 Beijing Institute of Genomics, Chinese A




E-mail: kbiggar@connect.carleton.ca (Biggar KK).cle, such as during prolonged bed rest, various disease
states or age-related sarcopenia, typically results in the
opposite eﬀect, i.e., atrophy of muscle [2]. Several molecu-
lar pathways involved in the development and maintenance
of skeletal muscle mass have been well characterized.
Major signaling pathways include the phosphoinositol
3-kinase (PI3-K)/Akt/mammalian target of rapamycin
(mTOR) pathway, the enzyme histone deacetylase 4
(HDAC4), the secreted protein myostatin and its associ-
ated membrane receptor (Acvr2b), as well as muscle-spe-
ciﬁc E3 ubiquitin ligases tripartite motif-containing
protein 63 (TRIM63) and muscle atrophy F-box (Atro-
gin-1) [3–5] (Figure S1). Transcription factors including
the forkhead box O (FoxO3a), myogenin, myogenic diﬀer-
entiation 1 (MyoD), myogenic factor (Myf5), myogenic
regulatory factor 4 (Mrf4), and myocyte enhancer factor
2 (MEF2A) are also crucial [2,4,6]. Development ofcademy of Sciences and Genetics Society of China. Published by Elsevier
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adult skeletal muscle, and any changes leading to hypertro-
phy or atrophy typically fall under the control of one or
more of these biological factors.
With the discovery of microRNAs (miRNAs), the small
non-coding RNAs capable of regulating protein expression
within a cell, additional post-transcriptional modes of reg-
ulation in skeletal muscle are being elucidated. With the aid
of the miRNA-initiated silencing complex (miRISC), these
17–22 nucleotide transcripts are able to bind with full or
partial complementarity usually to the 3’ UTR of mRNA
targets [7–9]. Target binding either inhibits translation or
leads to mRNA degradation [7–9]. This form of gene
expression control at the post-transcriptional level has been
shown to be of great importance in mammalian systems; to
date, miRNAs are known to be critically involved in bio-
logical development, cell diﬀerentiation, apoptosis, cell-
cycle control, stress response and disease pathogenesis
[7,10–12].
A collection of miRNAs have been shown to be regu-
lated during periods of skeletal muscle atrophy; these
include miR-1a-1, miR-29b, miR-181b, miR-15a, miR-
20a, miR-206, miR-128-1, miR-21, miR-23a and miR-107
[6,13,14]. Target validation has illustrated some ties, both
direct and indirect, between these miRNAs and the host
of muscle-speciﬁc eﬀects of the aforementioned factors
(Figure S1). Thus, miRNAs are critically involved in devel-
opment, maintenance and adaptation of skeletal muscle [6].
In order to further characterize the roles of miRNAs in
muscle metabolism, we turned to an unusual model of
mammalian muscle metabolism: hibernation. Many small
mammals use hibernation to survive over the winter
months when food is scarce and cold environmental tem-
peratures place high demands on thermogenesis if a high
constant body temperature (Tb) is to be maintained. For
example, body fat reserves of hibernating little brown bats,
Myotis lucifugus, would last only about 25 days if the ani-
mals maintained euthermia but by entering prolonged peri-
ods of torpor during which Tb falls to near ambient, the
bats readily endure a 7–9 month hibernation season with-
out eating [15]. Indeed, M. lucifugus may remain in con-
stant torpor for several weeks at a time during the
hibernation season. A recent study reported torpor bout
durations of 2–7 weeks for free-ranging little brown bats
(interspersed with short arousals back to euthermia) [16].
Much is known about the physiology and biochemistry
of hibernation in this species (e.g., [16,17] and references
therein). Most mammals that undergo long periods of
immobility display signiﬁcant disuse atrophy of their skel-
etal muscles [2]. However, hibernators, includingM. lucifu-
gus, appear to avoid this negative outcome [18] despite
spending long weeks in torpor during the winter. Selected
molecular mechanisms are clearly at work to preserve both
skeletal muscle mass and functionality during hibernation.
The present study was undertaken to evaluate the
responses of aforementioned muscle-associated miRNAs
in the skeletal muscle metabolism of M. lucifugus duringhibernation. RT-PCR was employed to investigate
expression of these miRNAs in the pectoral muscle that
powers ﬂight in bats. The diﬀerential expression of sev-
eral miRNAs was identiﬁed during hibernation and sug-
gests an important role for these non-coding RNAs in
the maintenance of skeletal muscle. The protein expres-
sion of several important miRNA targets (Myostatin,
FoxO3a, HDAC4 and SMAD7) were also analyzed by
immunoblotting. The data also provide intriguing leads
for therapeutic targets that could be investigated to or
avoid muscle disuse atrophy in humans. Furthermore,
presence of all 10 miRNAs in bats, which until now
had only been predicted algorithmically from genome
searches, was veriﬁed by sequencing Sequences of these
miRNAs were identical to those of mouse, indicating
that the miRNA sequences in a member of the Chirop-
tera are highly conserved with those of a rodent, the
mouse (Mus musculus).
Results
MicroRNA expression during hibernation
To amplify the selected miRNAs, we used a modiﬁed stem-
loop procedure outlined by Biggar et al. [19]. This protocol
allows both ampliﬁcation and sequencing of mature miR-
NAs in organisms that have no previous miRNA annota-
tion. Our results show that the uniform FO ﬁber
composition of M. lucifugus pectoralis muscle does not
change with season, consistent with previous report [20].
We therefore examined the miRNA expression in the pec-
toral muscle ofM. lucifugus. Expression levels of miR-1a-1,
miR-29b, miR-181b, miR-15a, miR-20a, miR-206, miR-
128-1, miR-21, miR-23a and miR-107 in the pectoral mus-
cle of M. lucifugus were assessed by RT-PCR and all miR-
NA PCR products were conﬁrmed by sequencing. The
sequences of all mature miRNAs investigated were 100%
identical with the known mature miRNA sequences from
the house mouse, M. musculus.
We further compared the expression of these miRNAs
in hibernating bats (Tb  5–6 C) and aroused euthermic
bats (Tb  35–37 C). Eight miRNAs were signiﬁcantly
upregulated in muscle from torpid bats as compared to
euthermic controls (P < 0.05) (Figure 1). For example,
expression of miR-29b increased by 1.2 fold (1.2 ± 0.05)
and that of miR-23a increased by 1.63-fold (1.63 ± 0.07).
However, expression of miR-21 decreased substantially
during torpor, which corresponded to only 22% of the
expression in control (22 ± 2%; P < 0.05), whereas expres-
sion levels of miR-107 (1.00 ± 0.02) didn’t change signiﬁ-
cantly with hibernation.
Putative miRNA targets of the diﬀerentially-expressed
miRNAs
Targets of these diﬀerentially-expressed miRNAs were
analyzed based on the available literature regarding these
Figure 1 Eﬀect of hibernation on the expression of selected microRNAs in skeletal muscle of M. lucifugus
A. Representative RT-PCR data were shown for expression of indicated miRNAs under control and hibernation conditions. B. Relative expression of
miRNA-21, miR-1a-1, miR-29b, miR-107, miR-23a, miR-181b, miR-15a, miR-20a, miR-128 and miR-206. Expression of the indicated miRNAs was
normalized to that of 5S rRNA from the same pectoral muscle RNA samples and shown in histogram. Data are presented as means ± S.E.M of
independent samples from separate animals (n = 3–4). *indicated that expression of the indicated miRNA in hibernated bats was signiﬁcantly diﬀerent
from controls (P < 0.05).
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from an algorithm-based miRNA target identiﬁcation
database (TargetScan release 4.2; http://www.target-
scan.org/vert_42/). These potential targets include
ACVR2b, HDAC4, myostatin, FoxO3a, MEF2A, homeo-
box protein HoxA11, SMAD7, MyoD, TRIM63 and Atro-
gin-1. A summary of the putative targets of diﬀerentially
regulated miRNAs and their potential eﬀects in skeletal
muscle is provided in Table 1.
Protein expression
Immunoblotting was performed to examine the relative
expression of several key proteins in miRNA processingTable 1 Diﬀerential expression of miRNAs in skeletal muscle of M. lucifugus

















Note: No change is deﬁned as ‘NC’. a Indicates that data was obtained fromand muscle maintenance/atrophy. These include Dicer,
which is a major protein in processing of precursors into
mature miRNAs, and several proteins involved in induct-
ing or transducing pathways of muscle maintenance/atro-
phy, such as myostatin, FoxO3a, HDAC4 and SMAD7.
As shown in Figure 2, the relative expression of Dicer or
FoxO3a protein did not change between control and
hibernating states. However, the relative expression of
myostatin was found to decrease to 57 ± 4% of control
in response to hibernation (P < 0.05). Similarly, relative
expression of HDAC4 decreased to 61 ± 8% of that in
controls. However, the relative expression of SMAD7
was found to increase 1.73 ± 0.11 fold compared to con-
trols in response to hibernation (P < 0.05).and their putative targets
Potential eﬀects Reference
Enhance MyoD signaling; inhibit myostatin signaling [40]
Allow MEF2A signaling; inhibit TRIM63 expression [41]
Inhibit myostatin signaling [37]a
Enhance MyoD signaling [33]
Allow MEF2A signaling; inhibit TRIM63 expression [46]
Inhibit myostatin signaling a
Prevent TRIM63 and Atrogin-1 expression a
Prevent myostatin expression a
Allow MEF2A signaling; inhibit TRIM63 expression [42]
Inhibit myostatin signaling [42]
Inhibit myostatin signaling a
Inhibit myostatin signaling a
Prevent TRIM63 and Atrogin-1 expression [14]
Prevent muscle-speciﬁc protein ubiquitination [43,44]
Prevent muscle-speciﬁc protein ubiquitination
Targeting of the CTG trinucleotide repeat of DMPK [45]
TargetScan release 4.2 (http://www.targetscan.com/vert_42/).
Figure 2 Eﬀect of hibernation on the protein expression of Dicer and
myostatin in skeletal muscle of M. lucifugus
A. Representative immunoreactive bands were shown for Dicer, myostatin
and other proteins under control and hibernation conditions. B. Relative
expression of Dicer, myostatin, FoxO3a, HDAC4 and SMAD7 protein
between control and hibernating states. Expression of the indicated
proteins was normalized and shown in histogram. Histogram shows
normalized protein levels. Data are presented as means ± SEM of
independent samples from separate animals (n = 4). *indicated that
expression of the indicated protein in hibernated bats was signiﬁcantly
diﬀerent from controls (P < 0.05).
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Since their initial discovery, miRNAs have been implicated
in most major areas of biological function: development,
tissue diﬀerentiation and maintenance, cell cycle control,
apoptosis, and metabolism. Perhaps as a result of their
clear importance in regulating biological functions, dysreg-
ulation of miRNAs has been determined to exist in various
disease states such as cancer, diabetes, muscular dystrophy
and heart disease [21]. These small regulatory molecules
provide immense potential as applied therapies or thera-
peutic targets, and hence it is useful to determine how miR-
NAs respond in diverse physiological situations including
animal survival of extreme environmental stress. An exam-
ple of such a model system is the avoidance of muscle dis-
use atrophy in bats and other hibernating mammals over
the winter months [18,22,23]. While expression proﬁling
of transcription factors and various other proteins has been
undertaken to investigate cellular processes that may be
involved in this lack of muscle degradation [22–25], our
lab is the ﬁrst to explore the possible contribution of miR-
NA regulation to create an insightful outline of the molec-
ular mechanisms at work to minimize muscle disuseatrophy in the pectoral muscle of little brown bats during
hibernation.
In M. lucifugus, diﬀerential miRNA expression in pec-
toral muscle appears to be a regulatory component of
hibernation and perhaps atrophy resistance (Figure 1).
Eight miRNAs were signiﬁcantly upregulated in the muscle
during torpor (including miR-1a-1, miR-9b, miR-23a,
miR-181b, miR-15a, miR-20a, miR-128 and miR-206)
and, in addition, miR-21 was found to be strongly down-
regulated. Interestingly, any changes of mature miRNA
transcripts appeared to be independent of Dicer protein
levels, which did not change during hibernation (Figure 2).
These miRNAs are all known to have regulatory roles in
muscle maintenance [6] and may aid in the atrophy resis-
tance of diﬀerentiated muscle cells by positively inﬂuencing
factors that promote muscle maintenance, while negatively
targeting factors that favor atrophy. Given the nature of
miRNA targeting and the translational impact of a single
miRNA, even relatively small changes in miRNA expres-
sion (1.2 to 1.6-fold) as seen in this study, may facilitate
rapid translational repression and/or degradation of target
genes. The extent to which combinatorial mRNA-miRNA
pairing occurs, may allow the expression of key genes nec-
essary for survival (Figure S1).
MEF2A, a myogenic transcription factor, is known to
be epigenetically repressed by HDAC4 [26]. Interestingly,
the expression of HDAC4 protein was found to decrease
during hibernation while its mRNA is negatively regulated
by the miRNAs miR-1a-1, miR-206 and miR-29b, all of
which show increased expression in torpid bat skeletal
muscle (Figures 1 and 2). The increased expression of
HDAC4 has also been linked to positive regulation of the
pro-atrophy factor, muscle-speciﬁc E3 ubiquitin ligase
TRIM63, in denervation atrophy models [27]. The ubiqui-
tin proteasome system (including TRIM63 and Atrogin-1)
has been estimated to account for up to 80% of protein
degradation during muscle wasting [28,29]. Expression of
both TRIM63 and Atrogin-1 are negatively regulated by
miR-23a, a miRNA shown to be upregulated during hiber-
nation, and is positively regulated by transcription factor
FoxO3a [28]. FoxO3a is also a predicted target of both
miR-29b and miR-128, two miRNAs that are also upregu-
lated in skeletal muscle during hibernation. Interestingly,
similar to muscle atrophy studies in the plantaris muscle
tissue of 13-lined ground squirrels, an organism that is also
able to undergo winter torpor, this study found no signiﬁ-
cant change in FoxO3a protein expression during torpor
[30]. These results suggest that FoxO3a protein may
undergo additional modes of regulation including either
reduced rates of protein degradation or post-translational
modiﬁcation.
As one of the myogenic regulator factors, MyoD is a key
regulator of muscle diﬀerentiation and maintenance as
shown through knockout experiments in mice [31]. Addi-
tionally, HoxA11 is a known repressor of MyoD transcrip-
tional activity [32]. Interestingly, it has been shown that
HoxA11 is a target of miR-181b, a miRNA that we have
Kornfeld SF et al /Muscle MicroRNA Regulation During Hibernation 299shown to increase expression in skeletal muscle during
hibernation [33]. It is possible that the increased expression
of miR-181b may indirectly promote MyoD regulation of
myogenesis. In addition to the possible contribution of
miR-181b, a signiﬁcant downregulation of miR-21 (to just
20% of control values) may also indirectly contribute to
promote MyoD signaling. miR-21 has been shown to tar-
get SMAD7 and a decreased expression of miR-21 may
act to inﬂuence the increase of SMAD7 protein expression
as seen in this study (Figure 2). Interestingly, the function
of SMAD7 in myocytes is to promote MyoD-dependent
myogenesis, via a strong positive feedback loop, and also
represses pro-atrophic myostatin signaling [34,35]. To this
regard, Myostatin, a protein shown in this study to
decrease during hibernation in pectoral muscle, is a strong
negative regulator of muscle diﬀerentiation and a predicted
target of miR-29b (Figure 2). Myostatin is a secreted pro-
tein that exerts its function onto myocytes by interacting
with cell surface activin type II receptors [36]. Control of
myostatin signaling in hibernating M. lucifugus may not
only be control via increased SMAD7 protein expression,
but though the repression of activin type II receptor,
ACVR2b. This receptor is a known target of miR-1a-1
and a predicted target of miR-206, miR-15a and miR-
20a, all miRNAs with upregulated expression in skeletal
muscle of hibernating bats [37].
Previous research has shown that little or no atrophy
occurs during hibernation in several species of bats
[18,22–25]. The common expression patterns among the
miRNAs examined in the present study suggest the promo-
tion of skeletal muscle maintenance and the prevention of
myostatin and ubiquitin ligase directed atrophy. Studies
of muscle atrophy in small mammalian hibernators, such
as the little brown bat, may be useful in deducing natural
pathways of preventing muscle atrophy during extended
period of disuse and disease states such as amyotrophic lat-
eral sclerosis and cachexia.
Materials and methods
Animals
Collection and treatment of little brown bats was as
described previously in Eddy and Storey [38]. Brieﬂy,
bats each weighing 78 g were collected from caves near
Sherbrooke, Quebec, at an air temperature of 5 C. The
bats were awakened by collection and remained euther-
mic during transport to Universite´ de Sherbrooke. Upon
arrival, half the animals were allowed to re-enter torpor
in a cold room at 5 C; full torpor was reached again in
10–12 h. Other bats were kept under euthermic condi-
tions at an environmental temperature of 23–24 C.
Pre-calibrated miniature temperature-sensitive radio
transmitters (SRX-400; LOTEK Engineering) were
attached to the bats in order to monitor Tb at 5 min
intervals. To do this, transmitters were attached in the
interscapular region with Skin-Bond surgical adhesive(Allegro Medical Supplies, Bolingbrook, IL, USA) and
skin temperature was used to approximate Tb. Immedi-
ately before sampling, euthermic bats showed Tb of 35–
37 C, whereas torpid bats showed Tb of 5–6 C. Euther-
mic bats were sacriﬁced 2 days post collection, whereas
torpid bats were sacriﬁced 36–38 h after re-establishment
of full torpor. Animals were killed by cervical dislocation
and then tissues were quickly excised, stored in liquid
nitrogen, and sent to Carleton University. Tissues were
kept at 80 C until used.
Protein isolation
Soluble protein samples of frozen pectoral muscle (0.5 g)
from individual bats were prepared in a similar manner
to Biggar and Storey [39]. Protein concentrations were
measured using the BioRad protein assay (Cat# 500-
0006) and adjusted to 10 lg/lL in homogenizing buﬀer
for all samples. The samples were denatured by mixing
with 2 SDS loading buﬀer (100 mM Tris-base, 4% w/v
SDS, 20% v/v glycerol, 0.2% w/v bromophenol blue and
10% v/v 2-mercaptoethanol) and incubating in boiling
water for 5 min. Samples were then stored at -80 C until
use.
Immunoblotting
Aliquots containing 20 lg protein were separated and were
then electroblotted onto polyvinylidenediﬂuoride (PVDF)
membrane (Cat# IPVH00010, Millipore) using a BioRad
mini Trans-Blot cell. Immunobotting was carried out as
described previously [39]. The primary antibodies used in
this study include rabbit anti-Dicer polyclonal antibody
(Cat# sc-30226, Santa Cruz), rabbit anti-myostatin poly-
clonal antibody (Cat# ab3239, Millipore), goat anti-
FoxO3a polyclonal antibody (Cat# sc-9813, Santa Cruz),
rabbit anti-HDAC4 polyclonal antibody (Cat# A00429,
GenScript) and rabbit anti-SMAD7 polyclonal antibody
(Cat# sc-11392, Santa Cruz). All primary antibodies were
diluted 1:1000. Signals were revealed by using HRP-conju-
gated secondary antibodies (1:1000) for development using
enhanced chemiluminescence. The Dicer band was found
at 200 kDa, myostatin at 25 kDa, FoxO3a at
90 kDa, HDAC4 at 120 kDa and SMAD7 at 45 kDa.
RNA isolation
Approximately 50 mg of frozen skeletal muscle from indi-
vidual animals was used for each sample. Total RNAs were
extracted from frozen tissue homogenized in 1 mL of Tri-
zol reagent (Invitrogen) as described previously [39].
RNA quality was examined by measuring the ratio of
OD260/OD280; only samples with OD260/OD280 >1.8 were
used for further experiments. Further quality validation
was done by running 2 lg of total RNA on a 1% agarose
gel to ensure the presence of normally abundant 18S and
28S rRNAs.
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RT-PCR of miRNAs was conducted according to Biggar
et al. [19]. An aliquot of 5 lL total RNA (0.2 lg/lL) was
added to 5 lL of stem-loop primer (250 nM). Sequences
for stem-loop primers are listed in Table S1. To anneal
the stem-loop primer to the target miRNA, a reaction
was carried out as follows: 5 min at 95 C, followed by
5 min at 60 C. Reactions were then centrifuged and held
on ice for 1 min before starting the reverse transcription.
The ampliﬁcation reaction was then carried out as follows:
16 C for 30 min followed by 60 cycles of 20 C for 30 s,
42 C for 30 s, then 50 C for 1 s and a ﬁnal single cycle
of 85 C for 5 min.
PCR ampliﬁcation
PCR was performed to amplify the mature miRNA targets.
Forward primers for all miRNAs were designed based on
conserved mature miRNA sequences and listed in
Table S1. A universal primer (50-CTCACAGTACGTTG
GTATCCTTGTG-30), complementary to the stem-loop
sequence, was used as the reverse primer in all ampliﬁca-
tions. Ampliﬁcation was carried out using miRNA-speciﬁc
cDNA template, miRNA-speciﬁc forward primer and
universal reverse primer with the following program:
95 C for 10 min, followed by 30 cycles of 95 C for 15 s
and 60 C for 1 min, and then a ﬁnal hold at 4 C.
The ampliﬁed products were then mixed with SYBR
Green I nucleic acid gel stain (Invitrogen) and loaded onto
2.5% agarose for electrophoresis. The bands from the most
dilute cDNA sample that yielded a visible product were
used for quantiﬁcation, ensuring that PCR products did
not reach ampliﬁcation saturation. All PCR products were
sent to BioBasic (Markham, ON, Canada) for sequencing
using a shortened universal reverse primer (50-CTCACAG
TACGTTGG-30) to increase sequence coverage.
Quantiﬁcation and statistics
Bands of proteins, miRNAs and 5S rRNA were visualized
and analyzed using the ChemiGenius BioImaging System
and the GeneTools software (Syngene, MD, USA). To cor-
rect any minor variations in sample loading, immunoblot
band intensity in each lane was normalized against a strong
band in the same lane stained by Coomassie blue, which
showed constant intensity across all samples and was
well-separated from the area of the gel containing the
immunoreactive protein. For RT-PCR, all miRNA bands
were standardized against the intensity of the correspond-
ing 5S rRNA band from the same RNA sample. Statistical
analysis was performed using the Students t-test with a
sample size of n = 3–4. Expression diﬀerences were consid-
ered signiﬁcant based on P < 0.05. Data are reported as
mean standardized band densities ± SEM for skeletal mus-
cle samples from euthermic control vs. torpid bats.Authors’ contributions
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